605016.SS SHH
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd.
1W: +3.2%
1M: -0.4%
3M: -18.1%
YTD: -15.3%
1Y: +4.3%
3Y: +50.9%
5Y: +112.2%
¥21.11 ($3.15)
+0.38 (+1.83%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Balance Sheet Trends
Total Assets
$2.0B
+14.8% ▲
5Y CAGR: +21.7%
Total Liabilities
$334M
+35.7% ▲
5Y CAGR: +16.3%
Shareholders Equity
$1.7B
+11.4% ▲
5Y CAGR: +23.0%
Cash & Investments
$439M
+2.5% ▲
5Y CAGR: +39.0%
Total Debt
$11M
+1656.4% ▲
5Y CAGR: -27.2%
Net Debt
-$276M
-58.3% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $141M | $305M | $192M | $176M | $287M |
| Short-Term Investments | $0 | $248M | $330M | $253M | $152M |
| Cash & ST Investments | $141M | $554M | $522M | $429M | $439M |
| Net Receivables | $127M | $145M | $155M | $174M | $241M |
| Inventory | $90M | $122M | $168M | $152M | $187M |
| Other Current Assets | $16M | $13M | $13M | $9M | $23M |
| Total Current Assets | $374M | $832M | $856M | $774M | $901M |
| Property, Plant & Equip. | $379M | $370M | $501M | $854M | $988M |
| Goodwill & Intangibles | $16M | $15M | $15M | $14M | $18M |
| Long-Term Investments | $56M | -$191M | -$271M | -$194M | -$91M |
| Other Non-Current Assets | $8M | $253M | $369M | $306M | $191M |
| Total Non-Current Assets | $462M | $451M | $616M | $980M | $1.1B |
| Total Assets | $836M | $1.3B | $1.5B | $1.8B | $2.0B |
| — Liabilities — | |||||
| Accounts Payable | $52M | $46M | $93M | $171M | $243M |
| Short-Term Debt | $68M | $1M | $0 | $0 | $10M |
| Deferred Revenue | $3M | $7M | $4M | $3M | $0 |
| Other Current Liabilities | $12M | $17M | $5M | $35M | $5M |
| Total Current Liabilities | $136M | $71M | $121M | $242M | $302M |
| Long-Term Debt | $0 | $0 | $14K | $0 | $0 |
| Other Non-Current Liab. | $0 | $0 | $14K | $0 | $0 |
| Total Non-Current Liabilities | $9M | $8M | $6M | $5M | $32M |
| Total Liabilities | $145M | $79M | $127M | $246M | $334M |
| — Equity — | |||||
| Common Stock | $95M | $127M | $178M | $249M | $323M |
| Retained Earnings | $294M | $388M | $513M | $657M | $802M |
| Accumulated OCI | $302M | $58M | $74M | $94M | $120M |
| Total Stockholders Equity | $691M | $1.2B | $1.3B | $1.5B | $1.7B |
| Total Liabilities & Equity | $836M | $1.3B | $1.5B | $1.8B | $2.0B |
| — Key Metrics — | |||||
| Total Debt | $68M | $3M | $1M | $627K | $11M |
| Net Debt | -$73M | -$303M | -$190M | -$174M | -$276M |
| Total Investments | $56M | $57M | $59M | $59M | $61M |